[ET Net News Agency, 8 April 2026] UBS lowered the target price for Ali Health (00241) to HKD4.1 from HKD4.7 and maintained the "sell" rating.
The research house said it lowers EPS forecast over FY26-28 by 12%. (rc)
The research house said it lowers EPS forecast over FY26-28 by 12%. (rc)